<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://feeds.hanselman.com/feedblitz_rss.xslt"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	 xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0">
<channel>
	<title>News – Biotech Networks</title>
	<atom:link href="https://biotechnetworks.org/category/news/feed/" rel="self" type="application/rss+xml" />
	<link>https://biotechnetworks.org</link>
	<description></description>
	<lastBuildDate>Sat, 04 Apr 2026 01:25:00 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>
<image>
	<url>https://biotechnetworks.org/wp-content/uploads/2023/05/Biotech-Networks-favicon-150x150.png</url>
	<title>News &#8211; Biotech Networks</title>
	<link>https://biotechnetworks.org</link>
	<width>32</width>
	<height>32</height>
</image>
<meta xmlns="http://www.w3.org/1999/xhtml" name="robots" content="noindex" />
<item>
<feedburner:origLink>https://sfbn.org/san-francisco-biotech-news/2026/04/01/gilead-extends-tender-offer-to-acquire-arcellx/?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=uc-davis-lands-15-8m-nih-grant-to-expand-latino-brain-aging-study-amid-funding-uncertainty&amp;utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=gilead-extends-tender-offer-to-acquire-arcellx</feedburner:origLink>
		<title>Gilead Extends Tender Offer to Acquire Arcellx</title>
		<link>https://feeds.hanselman.com/~/953215466/0/category~Gilead-Extends-Tender-Offer-to-Acquire-Arcellx/</link>
		
		<dc:creator><![CDATA[SFBN]]></dc:creator>
		<pubDate>Sat, 04 Apr 2026 01:25:00 +0000</pubDate>
				<category><![CDATA[News]]></category>
		<category><![CDATA[San Francisco Biotech Trending News]]></category>
		<category><![CDATA[Syndication]]></category>
		<guid isPermaLink="false">http://www.inoreader.com/article/3a9c6e76e0704ac7</guid>
					<description><![CDATA[FOSTER CITY, Calif.–(BUSINESS WIRE)–Gilead Sciences, Inc. (Nasdaq: GILD) today extended the expiration of the tender offer to purchase all outstanding shares of common stock of Arcellx. The offer remains at a purchase price of (1) <a rel="NOFOLLOW" class="mh-excerpt-more" href="https://sfbn.org/san-francisco-biotech-news/2026/04/01/gilead-extends-tender-offer-to-acquire-arcellx/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=uc-davis-lands-15-8m-nih-grant-to-expand-latino-brain-aging-study-amid-funding-uncertainty" title="Gilead Extends Tender Offer to Acquire Arcellx">[...]</a><div style="clear:both;padding-top:0.2em;"><a title="Like on Facebook" href="https://feeds.hanselman.com/_/28/953215466/category"><img height="20" src="https://assets.feedblitz.com/i/fblike20.png" style="border:0;margin:0;padding:0;"></a>&#160;<a title="Pin it!" href="https://feeds.hanselman.com/_/29/953215466/category,"><img height="20" src="https://assets.feedblitz.com/i/pinterest20.png" style="border:0;margin:0;padding:0;"></a>&#160;<a title="Post to X.com" href="https://feeds.hanselman.com/_/24/953215466/category"><img height="20" src="https://assets.feedblitz.com/i/x.png" style="border:0;margin:0;padding:0;"></a>&#160;<a title="Subscribe by email" href="https://feeds.hanselman.com/_/19/953215466/category"><img height="20" src="https://assets.feedblitz.com/i/email20.png" style="border:0;margin:0;padding:0;"></a>&#160;<a title="Subscribe by RSS" href="https://feeds.hanselman.com/_/20/953215466/category"><img height="20" src="https://assets.feedblitz.com/i/rss20.png" style="border:0;margin:0;padding:0;"></a>&nbsp;<h3 style="clear:left;padding-top:10px">Related Stories</h3><ul><li><a rel="NOFOLLOW" href="https://sfbn.org/san-francisco-biotech-news/2026/04/03/uc-davis-lands-15-8m-nih-grant-to-expand-latino-brain-aging-study-amid-funding-uncertainty/?utm_source=rss&utm_medium=rss&utm_campaign=uc-davis-lands-15-8m-nih-grant-to-expand-latino-brain-aging-study-amid-funding-uncertainty">UC Davis lands $15.8M NIH grant to expand Latino brain aging study amid funding uncertainty</a></li><li><a rel="NOFOLLOW" href="https://sfbn.org/san-francisco-biotech-news/2026/04/03/nnb-nutrition-powers-next-generation-of-functional-beverages-with-geniuspure-featured-in-new-launches-from-update-bucked-up-and-life-cider-x/?utm_source=rss&utm_medium=rss&utm_campaign=nnb-nutrition-powers-next-generation-of-functional-beverages-with-geniuspure-featured-in-new-launches-from-update-bucked-up-and-life-cider-x">NNB Nutrition Powers Next Generation of Functional Beverages with GeniusPure&#x2122;, Featured in New Launches from Update, Bucked Up, and Life Cider X</a></li><li><a rel="NOFOLLOW" href="https://sfbn.org/wp-content/uploads/2026/04/nnb-nutrition-powers-next-generation-of-functional-beverages-with-geniuspure-featured-in-new-launches-from-update-bucked-up-and-life-cider-x-1024x238.jpg">NNB Nutrition Powers Next Generation of Functional Beverages with GeniusPure&#x2122;, Featured in New Launches from Update, Bucked Up, and Life Cider X - Enclosure</a></li></ul>&#160;</div>]]>
</description><content:encoded><![CDATA[FOSTER CITY, Calif.–(BUSINESS WIRE)–Gilead Sciences, Inc. (Nasdaq: GILD) today extended the expiration of the tender offer to purchase all outstanding shares of common stock of Arcellx. The offer remains at a purchase price of (1) <a class="mh-excerpt-more" href="https://feeds.hanselman.com/~/t/0/0/category/~https://sfbn.org/san-francisco-biotech-news/2026/04/01/gilead-extends-tender-offer-to-acquire-arcellx/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=uc-davis-lands-15-8m-nih-grant-to-expand-latino-brain-aging-study-amid-funding-uncertainty" title="Gilead Extends Tender Offer to Acquire Arcellx">[...]</a><Img align="left" border="0" height="1" width="1" alt="" style="border:0;float:left;margin:0;padding:0;width:1px!important;height:1px!important;" hspace="0" src="https://feeds.hanselman.com/~/i/953215466/0/category">
<div style="clear:both;padding-top:0.2em;"><a title="Like on Facebook" href="https://feeds.hanselman.com/_/28/953215466/category"><img height="20" src="https://assets.feedblitz.com/i/fblike20.png" style="border:0;margin:0;padding:0;"></a>&#160;<a title="Pin it!" href="https://feeds.hanselman.com/_/29/953215466/category,"><img height="20" src="https://assets.feedblitz.com/i/pinterest20.png" style="border:0;margin:0;padding:0;"></a>&#160;<a title="Post to X.com" href="https://feeds.hanselman.com/_/24/953215466/category"><img height="20" src="https://assets.feedblitz.com/i/x.png" style="border:0;margin:0;padding:0;"></a>&#160;<a title="Subscribe by email" href="https://feeds.hanselman.com/_/19/953215466/category"><img height="20" src="https://assets.feedblitz.com/i/email20.png" style="border:0;margin:0;padding:0;"></a>&#160;<a title="Subscribe by RSS" href="https://feeds.hanselman.com/_/20/953215466/category"><img height="20" src="https://assets.feedblitz.com/i/rss20.png" style="border:0;margin:0;padding:0;"></a>&nbsp;<h3 style="clear:left;padding-top:10px">Related Stories</h3><ul><li><a rel="NOFOLLOW" href="https://sfbn.org/san-francisco-biotech-news/2026/04/03/uc-davis-lands-15-8m-nih-grant-to-expand-latino-brain-aging-study-amid-funding-uncertainty/?utm_source=rss&utm_medium=rss&utm_campaign=uc-davis-lands-15-8m-nih-grant-to-expand-latino-brain-aging-study-amid-funding-uncertainty">UC Davis lands $15.8M NIH grant to expand Latino brain aging study amid funding uncertainty</a></li><li><a rel="NOFOLLOW" href="https://sfbn.org/san-francisco-biotech-news/2026/04/03/nnb-nutrition-powers-next-generation-of-functional-beverages-with-geniuspure-featured-in-new-launches-from-update-bucked-up-and-life-cider-x/?utm_source=rss&utm_medium=rss&utm_campaign=nnb-nutrition-powers-next-generation-of-functional-beverages-with-geniuspure-featured-in-new-launches-from-update-bucked-up-and-life-cider-x">NNB Nutrition Powers Next Generation of Functional Beverages with GeniusPure&#x2122;, Featured in New Launches from Update, Bucked Up, and Life Cider X</a></li><li><a rel="NOFOLLOW" href="https://sfbn.org/wp-content/uploads/2026/04/nnb-nutrition-powers-next-generation-of-functional-beverages-with-geniuspure-featured-in-new-launches-from-update-bucked-up-and-life-cider-x-1024x238.jpg">NNB Nutrition Powers Next Generation of Functional Beverages with GeniusPure&#x2122;, Featured in New Launches from Update, Bucked Up, and Life Cider X - Enclosure</a></li></ul>&#160;</div>]]>
</content:encoded></item>
<item>
<feedburner:origLink>https://sdbn.org/san-diego-biotech-news/2026/04/03/grandevity-launches-vitality-and-energy-for-adults-aged-50-to-100/?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=grandevity-launches-vitality-and-energy-for-adults-aged-50-to-100</feedburner:origLink>
		<title>GRANDEVITY Launches: Vitality and Energy for Adults Aged 50 to 100</title>
		<link>https://feeds.hanselman.com/~/953215469/0/category~GRANDEVITY-Launches-Vitality-and-Energy-for-Adults-Aged-to/</link>
		
		<dc:creator><![CDATA[SDBN]]></dc:creator>
		<pubDate>Sat, 04 Apr 2026 01:22:20 +0000</pubDate>
				<category><![CDATA[News]]></category>
		<category><![CDATA[San Diego Biotech Trending News]]></category>
		<category><![CDATA[Syndication]]></category>
		<guid isPermaLink="false">http://www.inoreader.com/article/3a9c6e76e07073b6</guid>
					<description><![CDATA[GRANDEVITY Definition: “Great Age, Long Life, Longevity” SAN DIEGO, April 3, 2026 /PRNewswire/ — Today, GRANDEVITY officially launches as a premium plant-based wellness brand dedicated to helping adults aged 50 to 100 complement their healthy <a rel="NOFOLLOW" class="mh-excerpt-more" href="https://sdbn.org/san-diego-biotech-news/2026/04/03/grandevity-launches-vitality-and-energy-for-adults-aged-50-to-100/" title="GRANDEVITY Launches: Vitality and Energy for Adults Aged 50 to 100">[...]</a><div style="clear:both;padding-top:0.2em;"><a title="Like on Facebook" href="https://feeds.hanselman.com/_/28/953215469/category"><img height="20" src="https://assets.feedblitz.com/i/fblike20.png" style="border:0;margin:0;padding:0;"></a>&#160;<a title="Pin it!" href="https://feeds.hanselman.com/_/29/953215469/category,"><img height="20" src="https://assets.feedblitz.com/i/pinterest20.png" style="border:0;margin:0;padding:0;"></a>&#160;<a title="Post to X.com" href="https://feeds.hanselman.com/_/24/953215469/category"><img height="20" src="https://assets.feedblitz.com/i/x.png" style="border:0;margin:0;padding:0;"></a>&#160;<a title="Subscribe by email" href="https://feeds.hanselman.com/_/19/953215469/category"><img height="20" src="https://assets.feedblitz.com/i/email20.png" style="border:0;margin:0;padding:0;"></a>&#160;<a title="Subscribe by RSS" href="https://feeds.hanselman.com/_/20/953215469/category"><img height="20" src="https://assets.feedblitz.com/i/rss20.png" style="border:0;margin:0;padding:0;"></a>&nbsp;<h3 style="clear:left;padding-top:10px">Related Stories</h3><ul><li><a rel="NOFOLLOW" href="https://sdbn.org/san-diego-biotech-news/2026/04/02/unprecedented-early-stage-cancer-detection-presented-at-aacr-2026/?utm_source=rss&utm_medium=rss&utm_campaign=unprecedented-early-stage-cancer-detection-presented-at-aacr-2026">Unprecedented Early-Stage Cancer Detection Presented at AACR 2026</a></li><li><a rel="NOFOLLOW" href="https://sdbn.org/san-diego-biotech-news/2026/03/11/ixcells-biotechnologies-reaches-ipsc-line-delivery-milestone-in-collaboration-with-global-biotechnology-company/?utm_source=rss&utm_medium=rss&utm_campaign=ixcells-biotechnologies-reaches-ipsc-line-delivery-milestone-in-collaboration-with-global-biotechnology-company">iXCells Biotechnologies Reaches iPSC Line Delivery Milestone in Collaboration With Global Biotechnology Company</a></li><li><a rel="NOFOLLOW" href="https://sdbn.org/san-diego-biotech-news/2026/04/03/grandevity-launches-vitality-and-energy-for-adults-aged-50-to-100/">GRANDEVITY Launches: Vitality and Energy for Adults Aged 50 to 100</a></li></ul>&#160;</div>]]>
</description><content:encoded><![CDATA[GRANDEVITY Definition: “Great Age, Long Life, Longevity” SAN DIEGO, April 3, 2026 /PRNewswire/ — Today, GRANDEVITY officially launches as a premium plant-based wellness brand dedicated to helping adults aged 50 to 100 complement their healthy <a class="mh-excerpt-more" href="https://feeds.hanselman.com/~/t/0/0/category/~https://sdbn.org/san-diego-biotech-news/2026/04/03/grandevity-launches-vitality-and-energy-for-adults-aged-50-to-100/" title="GRANDEVITY Launches: Vitality and Energy for Adults Aged 50 to 100">[...]</a><Img align="left" border="0" height="1" width="1" alt="" style="border:0;float:left;margin:0;padding:0;width:1px!important;height:1px!important;" hspace="0" src="https://feeds.hanselman.com/~/i/953215469/0/category">
<div style="clear:both;padding-top:0.2em;"><a title="Like on Facebook" href="https://feeds.hanselman.com/_/28/953215469/category"><img height="20" src="https://assets.feedblitz.com/i/fblike20.png" style="border:0;margin:0;padding:0;"></a>&#160;<a title="Pin it!" href="https://feeds.hanselman.com/_/29/953215469/category,"><img height="20" src="https://assets.feedblitz.com/i/pinterest20.png" style="border:0;margin:0;padding:0;"></a>&#160;<a title="Post to X.com" href="https://feeds.hanselman.com/_/24/953215469/category"><img height="20" src="https://assets.feedblitz.com/i/x.png" style="border:0;margin:0;padding:0;"></a>&#160;<a title="Subscribe by email" href="https://feeds.hanselman.com/_/19/953215469/category"><img height="20" src="https://assets.feedblitz.com/i/email20.png" style="border:0;margin:0;padding:0;"></a>&#160;<a title="Subscribe by RSS" href="https://feeds.hanselman.com/_/20/953215469/category"><img height="20" src="https://assets.feedblitz.com/i/rss20.png" style="border:0;margin:0;padding:0;"></a>&nbsp;<h3 style="clear:left;padding-top:10px">Related Stories</h3><ul><li><a rel="NOFOLLOW" href="https://sdbn.org/san-diego-biotech-news/2026/04/02/unprecedented-early-stage-cancer-detection-presented-at-aacr-2026/?utm_source=rss&utm_medium=rss&utm_campaign=unprecedented-early-stage-cancer-detection-presented-at-aacr-2026">Unprecedented Early-Stage Cancer Detection Presented at AACR 2026</a></li><li><a rel="NOFOLLOW" href="https://sdbn.org/san-diego-biotech-news/2026/03/11/ixcells-biotechnologies-reaches-ipsc-line-delivery-milestone-in-collaboration-with-global-biotechnology-company/?utm_source=rss&utm_medium=rss&utm_campaign=ixcells-biotechnologies-reaches-ipsc-line-delivery-milestone-in-collaboration-with-global-biotechnology-company">iXCells Biotechnologies Reaches iPSC Line Delivery Milestone in Collaboration With Global Biotechnology Company</a></li><li><a rel="NOFOLLOW" href="https://sdbn.org/san-diego-biotech-news/2026/04/03/grandevity-launches-vitality-and-energy-for-adults-aged-50-to-100/">GRANDEVITY Launches: Vitality and Energy for Adults Aged 50 to 100</a></li></ul>&#160;</div>]]>
</content:encoded></item>
<item>
<feedburner:origLink>https://bcbn.org/boston-cambridge-biotech-news/2026/04/02/sv-health-investors-acquires-epivax/?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=the-value-of-hope-drug-pricing-more-at-massbios-state-of-possible&amp;utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=sv-health-investors-acquires-epivax</feedburner:origLink>
		<title>SV Health Investors Acquires EpiVax</title>
		<link>https://feeds.hanselman.com/~/953194262/0/category~SV-Health-Investors-Acquires-EpiVax/</link>
		
		<dc:creator><![CDATA[BCBN]]></dc:creator>
		<pubDate>Fri, 03 Apr 2026 18:15:46 +0000</pubDate>
				<category><![CDATA[Boston Cambridge Biotech Trending News]]></category>
		<category><![CDATA[Syndication]]></category>
		<guid isPermaLink="false">http://www.inoreader.com/article/3a9c6e76e05f9347</guid>
					<description><![CDATA[BOSTON–(BUSINESS WIRE)–SV Health Investors (“SVHI”), a healthcare and life sciences focused private investment firm, announced today the acquisition of EpiVax, Inc. Headquartered in Providence, RI, EpiVax is a leading bioanalytical CRO specializing in immunogenicity risk <a rel="NOFOLLOW" class="mh-excerpt-more" href="https://bcbn.org/boston-cambridge-biotech-news/2026/04/02/sv-health-investors-acquires-epivax/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=the-value-of-hope-drug-pricing-more-at-massbios-state-of-possible" title="SV Health Investors Acquires EpiVax">[...]</a><div style="clear:both;padding-top:0.2em;"><a title="Like on Facebook" href="https://feeds.hanselman.com/_/28/953194262/category"><img height="20" src="https://assets.feedblitz.com/i/fblike20.png" style="border:0;margin:0;padding:0;"></a>&#160;<a title="Pin it!" href="https://feeds.hanselman.com/_/29/953194262/category,"><img height="20" src="https://assets.feedblitz.com/i/pinterest20.png" style="border:0;margin:0;padding:0;"></a>&#160;<a title="Post to X.com" href="https://feeds.hanselman.com/_/24/953194262/category"><img height="20" src="https://assets.feedblitz.com/i/x.png" style="border:0;margin:0;padding:0;"></a>&#160;<a title="Subscribe by email" href="https://feeds.hanselman.com/_/19/953194262/category"><img height="20" src="https://assets.feedblitz.com/i/email20.png" style="border:0;margin:0;padding:0;"></a>&#160;<a title="Subscribe by RSS" href="https://feeds.hanselman.com/_/20/953194262/category"><img height="20" src="https://assets.feedblitz.com/i/rss20.png" style="border:0;margin:0;padding:0;"></a>&nbsp;<h3 style="clear:left;padding-top:10px">Related Stories</h3><ul><li><a rel="NOFOLLOW" href="https://bcbn.org/boston-cambridge-biotech-news/2026/04/02/vericel-announces-barda-award-valued-at-up-to-197-million-for-procurement-and-advanced-development-of-nexobrid/?utm_source=rss&utm_medium=rss&utm_campaign=the-value-of-hope-drug-pricing-more-at-massbios-state-of-possible&utm_source=rss&utm_medium=rss&utm_campaign=vericel-announces-barda-award-valued-at-up-to-197-million-for-procurement-and-advanced-development-of-nexobrid">Vericel Announces BARDA Award Valued at up to $197 Million for Procurement and Advanced Development of NexoBrid</a></li><li><a rel="NOFOLLOW" href="https://bcbn.org/boston-cambridge-biotech-news/2026/03/30/stockwatch-wave-plummets-50-on-obesity-data/?utm_source=rss&utm_medium=rss&utm_campaign=toward-cheaper-cleaner-hydrogen-production&utm_source=rss&utm_medium=rss&utm_campaign=stockwatch-wave-plummets-50-on-obesity-data">StockWatch: Wave Plummets 50% on Obesity Data</a></li><li><a rel="NOFOLLOW" href="https://bcbn.org/boston-cambridge-biotech-news/2026/04/03/the-value-of-hope-drug-pricing-more-at-massbios-state-of-possible/?utm_source=rss&utm_medium=rss&utm_campaign=the-value-of-hope-drug-pricing-more-at-massbios-state-of-possible">The Value of Hope: Drug Pricing &#038; More at MassBio’s State of Possible</a></li></ul>&#160;</div>]]>
</description><content:encoded><![CDATA[BOSTON–(BUSINESS WIRE)–SV Health Investors (“SVHI”), a healthcare and life sciences focused private investment firm, announced today the acquisition of EpiVax, Inc. Headquartered in Providence, RI, EpiVax is a leading bioanalytical CRO specializing in immunogenicity risk <a class="mh-excerpt-more" href="https://feeds.hanselman.com/~/t/0/0/category/~https://bcbn.org/boston-cambridge-biotech-news/2026/04/02/sv-health-investors-acquires-epivax/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=the-value-of-hope-drug-pricing-more-at-massbios-state-of-possible" title="SV Health Investors Acquires EpiVax">[...]</a><Img align="left" border="0" height="1" width="1" alt="" style="border:0;float:left;margin:0;padding:0;width:1px!important;height:1px!important;" hspace="0" src="https://feeds.hanselman.com/~/i/953194262/0/category">
<div style="clear:both;padding-top:0.2em;"><a title="Like on Facebook" href="https://feeds.hanselman.com/_/28/953194262/category"><img height="20" src="https://assets.feedblitz.com/i/fblike20.png" style="border:0;margin:0;padding:0;"></a>&#160;<a title="Pin it!" href="https://feeds.hanselman.com/_/29/953194262/category,"><img height="20" src="https://assets.feedblitz.com/i/pinterest20.png" style="border:0;margin:0;padding:0;"></a>&#160;<a title="Post to X.com" href="https://feeds.hanselman.com/_/24/953194262/category"><img height="20" src="https://assets.feedblitz.com/i/x.png" style="border:0;margin:0;padding:0;"></a>&#160;<a title="Subscribe by email" href="https://feeds.hanselman.com/_/19/953194262/category"><img height="20" src="https://assets.feedblitz.com/i/email20.png" style="border:0;margin:0;padding:0;"></a>&#160;<a title="Subscribe by RSS" href="https://feeds.hanselman.com/_/20/953194262/category"><img height="20" src="https://assets.feedblitz.com/i/rss20.png" style="border:0;margin:0;padding:0;"></a>&nbsp;<h3 style="clear:left;padding-top:10px">Related Stories</h3><ul><li><a rel="NOFOLLOW" href="https://bcbn.org/boston-cambridge-biotech-news/2026/04/02/vericel-announces-barda-award-valued-at-up-to-197-million-for-procurement-and-advanced-development-of-nexobrid/?utm_source=rss&utm_medium=rss&utm_campaign=the-value-of-hope-drug-pricing-more-at-massbios-state-of-possible&utm_source=rss&utm_medium=rss&utm_campaign=vericel-announces-barda-award-valued-at-up-to-197-million-for-procurement-and-advanced-development-of-nexobrid">Vericel Announces BARDA Award Valued at up to $197 Million for Procurement and Advanced Development of NexoBrid</a></li><li><a rel="NOFOLLOW" href="https://bcbn.org/boston-cambridge-biotech-news/2026/03/30/stockwatch-wave-plummets-50-on-obesity-data/?utm_source=rss&utm_medium=rss&utm_campaign=toward-cheaper-cleaner-hydrogen-production&utm_source=rss&utm_medium=rss&utm_campaign=stockwatch-wave-plummets-50-on-obesity-data">StockWatch: Wave Plummets 50% on Obesity Data</a></li><li><a rel="NOFOLLOW" href="https://bcbn.org/boston-cambridge-biotech-news/2026/04/03/the-value-of-hope-drug-pricing-more-at-massbios-state-of-possible/?utm_source=rss&utm_medium=rss&utm_campaign=the-value-of-hope-drug-pricing-more-at-massbios-state-of-possible">The Value of Hope: Drug Pricing &#038; More at MassBio’s State of Possible</a></li></ul>&#160;</div>]]>
</content:encoded></item>
<item>
<feedburner:origLink>https://bcbn.org/boston-cambridge-biotech-news/2026/04/02/vericel-announces-barda-award-valued-at-up-to-197-million-for-procurement-and-advanced-development-of-nexobrid/?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=the-value-of-hope-drug-pricing-more-at-massbios-state-of-possible&amp;utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=vericel-announces-barda-award-valued-at-up-to-197-million-for-procurement-and-advanced-development-of-nexobrid</feedburner:origLink>
		<title>Vericel Announces BARDA Award Valued at up to $197 Million for Procurement and Advanced Development of NexoBrid</title>
		<link>https://feeds.hanselman.com/~/953194265/0/category~Vericel-Announces-BARDA-Award-Valued-at-up-to-Million-for-Procurement-and-Advanced-Development-of-NexoBrid/</link>
		
		<dc:creator><![CDATA[BCBN]]></dc:creator>
		<pubDate>Fri, 03 Apr 2026 18:15:46 +0000</pubDate>
				<category><![CDATA[Boston Cambridge Biotech Trending News]]></category>
		<category><![CDATA[Syndication]]></category>
		<guid isPermaLink="false">http://www.inoreader.com/article/3a9c6e76e05f9345</guid>
					<description><![CDATA[CAMBRIDGE, Mass., April 02, 2026 (GLOBE NEWSWIRE) — Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, has been awarded a ten-year contract valued at up to <a rel="NOFOLLOW" class="mh-excerpt-more" href="https://bcbn.org/boston-cambridge-biotech-news/2026/04/02/vericel-announces-barda-award-valued-at-up-to-197-million-for-procurement-and-advanced-development-of-nexobrid/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=the-value-of-hope-drug-pricing-more-at-massbios-state-of-possible" title="Vericel Announces BARDA Award Valued at up to $197 Million for Procurement and Advanced Development of NexoBrid">[...]</a><div style="clear:both;padding-top:0.2em;"><a title="Like on Facebook" href="https://feeds.hanselman.com/_/28/953194265/category"><img height="20" src="https://assets.feedblitz.com/i/fblike20.png" style="border:0;margin:0;padding:0;"></a>&#160;<a title="Pin it!" href="https://feeds.hanselman.com/_/29/953194265/category,"><img height="20" src="https://assets.feedblitz.com/i/pinterest20.png" style="border:0;margin:0;padding:0;"></a>&#160;<a title="Post to X.com" href="https://feeds.hanselman.com/_/24/953194265/category"><img height="20" src="https://assets.feedblitz.com/i/x.png" style="border:0;margin:0;padding:0;"></a>&#160;<a title="Subscribe by email" href="https://feeds.hanselman.com/_/19/953194265/category"><img height="20" src="https://assets.feedblitz.com/i/email20.png" style="border:0;margin:0;padding:0;"></a>&#160;<a title="Subscribe by RSS" href="https://feeds.hanselman.com/_/20/953194265/category"><img height="20" src="https://assets.feedblitz.com/i/rss20.png" style="border:0;margin:0;padding:0;"></a>&nbsp;<h3 style="clear:left;padding-top:10px">Related Stories</h3><ul><li><a rel="NOFOLLOW" href="https://bcbn.org/boston-cambridge-biotech-news/2026/04/02/sv-health-investors-acquires-epivax/?utm_source=rss&utm_medium=rss&utm_campaign=the-value-of-hope-drug-pricing-more-at-massbios-state-of-possible&utm_source=rss&utm_medium=rss&utm_campaign=sv-health-investors-acquires-epivax">SV Health Investors Acquires EpiVax</a></li><li><a rel="NOFOLLOW" href="https://bcbn.org/boston-cambridge-biotech-news/2026/03/30/stockwatch-wave-plummets-50-on-obesity-data/?utm_source=rss&utm_medium=rss&utm_campaign=toward-cheaper-cleaner-hydrogen-production&utm_source=rss&utm_medium=rss&utm_campaign=stockwatch-wave-plummets-50-on-obesity-data">StockWatch: Wave Plummets 50% on Obesity Data</a></li><li><a rel="NOFOLLOW" href="https://bcbn.org/boston-cambridge-biotech-news/2026/04/03/the-value-of-hope-drug-pricing-more-at-massbios-state-of-possible/?utm_source=rss&utm_medium=rss&utm_campaign=the-value-of-hope-drug-pricing-more-at-massbios-state-of-possible">The Value of Hope: Drug Pricing &#038; More at MassBio’s State of Possible</a></li></ul>&#160;</div>]]>
</description><content:encoded><![CDATA[CAMBRIDGE, Mass., April 02, 2026 (GLOBE NEWSWIRE) — Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, has been awarded a ten-year contract valued at up to <a class="mh-excerpt-more" href="https://feeds.hanselman.com/~/t/0/0/category/~https://bcbn.org/boston-cambridge-biotech-news/2026/04/02/vericel-announces-barda-award-valued-at-up-to-197-million-for-procurement-and-advanced-development-of-nexobrid/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=the-value-of-hope-drug-pricing-more-at-massbios-state-of-possible" title="Vericel Announces BARDA Award Valued at up to $197 Million for Procurement and Advanced Development of NexoBrid">[...]</a><Img align="left" border="0" height="1" width="1" alt="" style="border:0;float:left;margin:0;padding:0;width:1px!important;height:1px!important;" hspace="0" src="https://feeds.hanselman.com/~/i/953194265/0/category">
<div style="clear:both;padding-top:0.2em;"><a title="Like on Facebook" href="https://feeds.hanselman.com/_/28/953194265/category"><img height="20" src="https://assets.feedblitz.com/i/fblike20.png" style="border:0;margin:0;padding:0;"></a>&#160;<a title="Pin it!" href="https://feeds.hanselman.com/_/29/953194265/category,"><img height="20" src="https://assets.feedblitz.com/i/pinterest20.png" style="border:0;margin:0;padding:0;"></a>&#160;<a title="Post to X.com" href="https://feeds.hanselman.com/_/24/953194265/category"><img height="20" src="https://assets.feedblitz.com/i/x.png" style="border:0;margin:0;padding:0;"></a>&#160;<a title="Subscribe by email" href="https://feeds.hanselman.com/_/19/953194265/category"><img height="20" src="https://assets.feedblitz.com/i/email20.png" style="border:0;margin:0;padding:0;"></a>&#160;<a title="Subscribe by RSS" href="https://feeds.hanselman.com/_/20/953194265/category"><img height="20" src="https://assets.feedblitz.com/i/rss20.png" style="border:0;margin:0;padding:0;"></a>&nbsp;<h3 style="clear:left;padding-top:10px">Related Stories</h3><ul><li><a rel="NOFOLLOW" href="https://bcbn.org/boston-cambridge-biotech-news/2026/04/02/sv-health-investors-acquires-epivax/?utm_source=rss&utm_medium=rss&utm_campaign=the-value-of-hope-drug-pricing-more-at-massbios-state-of-possible&utm_source=rss&utm_medium=rss&utm_campaign=sv-health-investors-acquires-epivax">SV Health Investors Acquires EpiVax</a></li><li><a rel="NOFOLLOW" href="https://bcbn.org/boston-cambridge-biotech-news/2026/03/30/stockwatch-wave-plummets-50-on-obesity-data/?utm_source=rss&utm_medium=rss&utm_campaign=toward-cheaper-cleaner-hydrogen-production&utm_source=rss&utm_medium=rss&utm_campaign=stockwatch-wave-plummets-50-on-obesity-data">StockWatch: Wave Plummets 50% on Obesity Data</a></li><li><a rel="NOFOLLOW" href="https://bcbn.org/boston-cambridge-biotech-news/2026/04/03/the-value-of-hope-drug-pricing-more-at-massbios-state-of-possible/?utm_source=rss&utm_medium=rss&utm_campaign=the-value-of-hope-drug-pricing-more-at-massbios-state-of-possible">The Value of Hope: Drug Pricing &#038; More at MassBio’s State of Possible</a></li></ul>&#160;</div>]]>
</content:encoded></item>
<item>
<feedburner:origLink>https://dcbn.org/dc-maryland-virginia-biotech-news/2026/04/03/onecyte-and-kemp-proteins-announce-strategic-partnership-to-accelerate-high-performance-cell-line-development-for-next-generation-biologics/?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=onecyte-and-kemp-proteins-announce-strategic-partnership-to-accelerate-high-performance-cell-line-development-for-next-generation-biologics&amp;utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=onecyte-and-kemp-proteins-announce-strategic-partnership-to-accelerate-high-performance-cell-line-development-for-next-generation-biologics</feedburner:origLink>
		<title>OneCyte and Kemp Proteins Announce Strategic Partnership to Accelerate High-Performance Cell Line Development for Next-Generation Biologics</title>
		<link>https://feeds.hanselman.com/~/953175491/0/category~OneCyte-and-Kemp-Proteins-Announce-Strategic-Partnership-to-Accelerate-HighPerformance-Cell-Line-Development-for-NextGeneration-Biologics/</link>
		
		<dc:creator><![CDATA[DCBN]]></dc:creator>
		<pubDate>Fri, 03 Apr 2026 13:04:30 +0000</pubDate>
				<category><![CDATA[DC Maryland Virginia Biotech Trending News]]></category>
		<category><![CDATA[News]]></category>
		<category><![CDATA[Syndication]]></category>
		<guid isPermaLink="false">https://dcbn.org/dc-maryland-virginia-biotech-news/2026/04/03/onecyte-and-kemp-proteins-announce-strategic-partnership-to-accelerate-high-performance-cell-line-development-for-next-generation-biologics/</guid>
					<description><![CDATA[<p><img width="1200" height="1200" src="https://biotechnetworks.org/wp-content/uploads/2026/04/onecyte-and-kemp-proteins-announce-strategic-partnership-to-accelerate-high-performance-cell-line-development-for-next-generation-biologics.jpg" class="attachment-post-thumbnail size-post-thumbnail wp-post-image" alt="" decoding="async" fetchpriority="high" srcset="https://biotechnetworks.org/wp-content/uploads/2026/04/onecyte-and-kemp-proteins-announce-strategic-partnership-to-accelerate-high-performance-cell-line-development-for-next-generation-biologics.jpg 1200w, https://biotechnetworks.org/wp-content/uploads/2026/04/onecyte-and-kemp-proteins-announce-strategic-partnership-to-accelerate-high-performance-cell-line-development-for-next-generation-biologics-300x300.jpg 300w, https://feeds.hanselman.com/-/953212247/0/category.jpg 1024w, https://biotechnetworks.org/wp-content/uploads/2026/04/onecyte-and-kemp-proteins-announce-strategic-partnership-to-accelerate-high-performance-cell-line-development-for-next-generation-biologics-150x150.jpg 150w, https://biotechnetworks.org/wp-content/uploads/2026/04/onecyte-and-kemp-proteins-announce-strategic-partnership-to-accelerate-high-performance-cell-line-development-for-next-generation-biologics-768x768.jpg 768w" sizes="(max-width: 1200px) 100vw, 1200px" /></p>FREDERICK, Md., April 3, 2026 /PRNewswire/ &#8212; OneCyte, a leader in high-throughput single-cell analysis and cell line development technologies, and Kemp Proteins, a pioneer in protein engineering and expression solutions, today announced a strategic partnership <a rel="NOFOLLOW" class="mh-excerpt-more" href="https://dcbn.org/dc-maryland-virginia-biotech-news/2026/04/03/onecyte-and-kemp-proteins-announce-strategic-partnership-to-accelerate-high-performance-cell-line-development-for-next-generation-biologics/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=onecyte-and-kemp-proteins-announce-strategic-partnership-to-accelerate-high-performance-cell-line-development-for-next-generation-biologics" title="OneCyte and Kemp Proteins Announce Strategic Partnership to Accelerate High-Performance Cell Line Development for Next-Generation Biologics">[...]</a><div style="clear:both;padding-top:0.2em;"><a title="Like on Facebook" href="https://feeds.hanselman.com/_/28/953175491/category"><img height="20" src="https://assets.feedblitz.com/i/fblike20.png" style="border:0;margin:0;padding:0;"></a>&#160;<a title="Pin it!" href="https://feeds.hanselman.com/_/29/953175491/category,https%3a%2f%2fbiotechnetworks.org%2fwp-content%2fuploads%2f2026%2f04%2fonecyte-and-kemp-proteins-announce-strategic-partnership-to-accelerate-high-performance-cell-line-development-for-next-generation-biologics.jpg"><img height="20" src="https://assets.feedblitz.com/i/pinterest20.png" style="border:0;margin:0;padding:0;"></a>&#160;<a title="Post to X.com" href="https://feeds.hanselman.com/_/24/953175491/category"><img height="20" src="https://assets.feedblitz.com/i/x.png" style="border:0;margin:0;padding:0;"></a>&#160;<a title="Subscribe by email" href="https://feeds.hanselman.com/_/19/953175491/category"><img height="20" src="https://assets.feedblitz.com/i/email20.png" style="border:0;margin:0;padding:0;"></a>&#160;<a title="Subscribe by RSS" href="https://feeds.hanselman.com/_/20/953175491/category"><img height="20" src="https://assets.feedblitz.com/i/rss20.png" style="border:0;margin:0;padding:0;"></a>&nbsp;<h3 style="clear:left;padding-top:10px">Related Stories</h3><ul><li><a rel="NOFOLLOW" href="https://dcbn.org/wp-content/uploads/sites/6/2026/04/onecyte-and-kemp-proteins-announce-strategic-partnership-to-accelerate-high-performance-cell-line-development-for-next-generation-biologics-1024x1024.jpg">OneCyte and Kemp Proteins Announce Strategic Partnership to Accelerate High-Performance Cell Line Development for Next-Generation Biologics - Enclosure</a></li><li><a rel="NOFOLLOW" href="https://dcbn.org/dc-maryland-virginia-biotech-jobs/2026/04/04/junior-sales-associate-entry-level-bethesda-md-bethesda-md/?utm_source=rss&utm_medium=rss&utm_campaign=junior-sales-associate-entry-level-bethesda-md-bethesda-md">Junior Sales Associate &#8211; entry level &#8211; Bethesda, MD &#8211; Bethesda, MD</a></li><li><a rel="NOFOLLOW" href="https://dcbn.org/dc-maryland-virginia-biotech-jobs/2026/04/03/emerging-disruptive-biological-technology-analyst-frederick-md/?utm_source=rss&utm_medium=rss&utm_campaign=emerging-disruptive-biological-technology-analyst-frederick-md">Emerging &#038; Disruptive Biological Technology Analyst &#8211; Frederick, MD</a></li></ul>&#160;</div>]]>
</description>
		
		
		
		<enclosure url="https://feeds.hanselman.com/-/953212247/0/category.jpg" length="127869" type="image/jpeg" />
<feedburner:origEnclosureLink>https://biotechnetworks.org/wp-content/uploads/2026/04/onecyte-and-kemp-proteins-announce-strategic-partnership-to-accelerate-high-performance-cell-line-development-for-next-generation-biologics-1024x1024.jpg</feedburner:origEnclosureLink>
<content:encoded><![CDATA[<p><img width="1200" height="1200" src="https://biotechnetworks.org/wp-content/uploads/2026/04/onecyte-and-kemp-proteins-announce-strategic-partnership-to-accelerate-high-performance-cell-line-development-for-next-generation-biologics.jpg" class="attachment-post-thumbnail size-post-thumbnail wp-post-image" alt="" decoding="async" fetchpriority="high" srcset="https://biotechnetworks.org/wp-content/uploads/2026/04/onecyte-and-kemp-proteins-announce-strategic-partnership-to-accelerate-high-performance-cell-line-development-for-next-generation-biologics.jpg 1200w, https://biotechnetworks.org/wp-content/uploads/2026/04/onecyte-and-kemp-proteins-announce-strategic-partnership-to-accelerate-high-performance-cell-line-development-for-next-generation-biologics-300x300.jpg 300w, https://biotechnetworks.org/wp-content/uploads/2026/04/onecyte-and-kemp-proteins-announce-strategic-partnership-to-accelerate-high-performance-cell-line-development-for-next-generation-biologics-1024x1024.jpg 1024w, https://biotechnetworks.org/wp-content/uploads/2026/04/onecyte-and-kemp-proteins-announce-strategic-partnership-to-accelerate-high-performance-cell-line-development-for-next-generation-biologics-150x150.jpg 150w, https://biotechnetworks.org/wp-content/uploads/2026/04/onecyte-and-kemp-proteins-announce-strategic-partnership-to-accelerate-high-performance-cell-line-development-for-next-generation-biologics-768x768.jpg 768w" sizes="(max-width: 1200px) 100vw, 1200px" /></p>FREDERICK, Md., April 3, 2026 /PRNewswire/ &#8212; OneCyte, a leader in high-throughput single-cell analysis and cell line development technologies, and Kemp Proteins, a pioneer in protein engineering and expression solutions, today announced a strategic partnership <a class="mh-excerpt-more" href="https://feeds.hanselman.com/~/t/0/0/category/~https://dcbn.org/dc-maryland-virginia-biotech-news/2026/04/03/onecyte-and-kemp-proteins-announce-strategic-partnership-to-accelerate-high-performance-cell-line-development-for-next-generation-biologics/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=onecyte-and-kemp-proteins-announce-strategic-partnership-to-accelerate-high-performance-cell-line-development-for-next-generation-biologics" title="OneCyte and Kemp Proteins Announce Strategic Partnership to Accelerate High-Performance Cell Line Development for Next-Generation Biologics">[...]</a><Img align="left" border="0" height="1" width="1" alt="" style="border:0;float:left;margin:0;padding:0;width:1px!important;height:1px!important;" hspace="0" src="https://feeds.hanselman.com/~/i/953175491/0/category">
<div style="clear:both;padding-top:0.2em;"><a title="Like on Facebook" href="https://feeds.hanselman.com/_/28/953175491/category"><img height="20" src="https://assets.feedblitz.com/i/fblike20.png" style="border:0;margin:0;padding:0;"></a>&#160;<a title="Pin it!" href="https://feeds.hanselman.com/_/29/953175491/category,https%3a%2f%2fbiotechnetworks.org%2fwp-content%2fuploads%2f2026%2f04%2fonecyte-and-kemp-proteins-announce-strategic-partnership-to-accelerate-high-performance-cell-line-development-for-next-generation-biologics.jpg"><img height="20" src="https://assets.feedblitz.com/i/pinterest20.png" style="border:0;margin:0;padding:0;"></a>&#160;<a title="Post to X.com" href="https://feeds.hanselman.com/_/24/953175491/category"><img height="20" src="https://assets.feedblitz.com/i/x.png" style="border:0;margin:0;padding:0;"></a>&#160;<a title="Subscribe by email" href="https://feeds.hanselman.com/_/19/953175491/category"><img height="20" src="https://assets.feedblitz.com/i/email20.png" style="border:0;margin:0;padding:0;"></a>&#160;<a title="Subscribe by RSS" href="https://feeds.hanselman.com/_/20/953175491/category"><img height="20" src="https://assets.feedblitz.com/i/rss20.png" style="border:0;margin:0;padding:0;"></a>&nbsp;<h3 style="clear:left;padding-top:10px">Related Stories</h3><ul><li><a rel="NOFOLLOW" href="https://dcbn.org/wp-content/uploads/sites/6/2026/04/onecyte-and-kemp-proteins-announce-strategic-partnership-to-accelerate-high-performance-cell-line-development-for-next-generation-biologics-1024x1024.jpg">OneCyte and Kemp Proteins Announce Strategic Partnership to Accelerate High-Performance Cell Line Development for Next-Generation Biologics - Enclosure</a></li><li><a rel="NOFOLLOW" href="https://dcbn.org/dc-maryland-virginia-biotech-jobs/2026/04/04/junior-sales-associate-entry-level-bethesda-md-bethesda-md/?utm_source=rss&utm_medium=rss&utm_campaign=junior-sales-associate-entry-level-bethesda-md-bethesda-md">Junior Sales Associate &#8211; entry level &#8211; Bethesda, MD &#8211; Bethesda, MD</a></li><li><a rel="NOFOLLOW" href="https://dcbn.org/dc-maryland-virginia-biotech-jobs/2026/04/03/emerging-disruptive-biological-technology-analyst-frederick-md/?utm_source=rss&utm_medium=rss&utm_campaign=emerging-disruptive-biological-technology-analyst-frederick-md">Emerging &#038; Disruptive Biological Technology Analyst &#8211; Frederick, MD</a></li></ul>&#160;</div>]]>
</content:encoded></item>
<item>
<feedburner:origLink>https://ncbn.bio/north-carolina-biotech-news/2026/04/03/why-a-former-lego-lead-left-the-toy-giant-to-reinvent-social-gaming/?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=injectable-microgel-developed-to-reduce-bleeding-in-infants-undergoing-surgery&amp;utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=why-a-former-lego-lead-left-the-toy-giant-to-reinvent-social-gaming</feedburner:origLink>
		<title>Why a former Lego lead left the toy giant to reinvent social gaming</title>
		<link>https://feeds.hanselman.com/~/953212253/0/category~Why-a-former-Lego-lead-left-the-toy-giant-to-reinvent-social-gaming/</link>
		
		<dc:creator><![CDATA[NCBN]]></dc:creator>
		<pubDate>Fri, 03 Apr 2026 12:04:35 +0000</pubDate>
				<category><![CDATA[News]]></category>
		<category><![CDATA[North Carolina Region Trending News]]></category>
		<category><![CDATA[Syndication]]></category>
		<guid isPermaLink="false">https://ncbn.bio/north-carolina-biotech-news/2026/04/03/why-a-former-lego-lead-left-the-toy-giant-to-reinvent-social-gaming/</guid>
					<description><![CDATA[<p><img style="max-width:100% !important;height:auto !important;" width="200" xheight="133" src="https://biotechnetworks.org/wp-content/uploads/2026/04/why-a-former-lego-lead-left-the-toy-giant-to-reinvent-social-gaming.jpg" class="attachment-post-thumbnail size-post-thumbnail wp-post-image" alt=""  /></p>A former LEGO designer is targeting workplace loneliness with a handcrafted tabletop game manufactured in Chapel Hill. Click here to view original post Click Here to Publish/Feature Your Company or Product News with Biotech Networks <a rel="NOFOLLOW" class="mh-excerpt-more" href="https://ncbn.bio/north-carolina-biotech-news/2026/04/03/why-a-former-lego-lead-left-the-toy-giant-to-reinvent-social-gaming/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=injectable-microgel-developed-to-reduce-bleeding-in-infants-undergoing-surgery" title="Why a former Lego lead left the toy giant to reinvent social gaming">[...]</a><div style="clear:both;padding-top:0.2em;"><a title="Like on Facebook" href="https://feeds.hanselman.com/_/28/953212253/category"><img height="20" src="https://assets.feedblitz.com/i/fblike20.png" style="border:0;margin:0;padding:0;"></a>&#160;<a title="Pin it!" href="https://feeds.hanselman.com/_/29/953212253/category,https%3a%2f%2fbiotechnetworks.org%2fwp-content%2fuploads%2f2026%2f04%2fwhy-a-former-lego-lead-left-the-toy-giant-to-reinvent-social-gaming.jpg"><img height="20" src="https://assets.feedblitz.com/i/pinterest20.png" style="border:0;margin:0;padding:0;"></a>&#160;<a title="Post to X.com" href="https://feeds.hanselman.com/_/24/953212253/category"><img height="20" src="https://assets.feedblitz.com/i/x.png" style="border:0;margin:0;padding:0;"></a>&#160;<a title="Subscribe by email" href="https://feeds.hanselman.com/_/19/953212253/category"><img height="20" src="https://assets.feedblitz.com/i/email20.png" style="border:0;margin:0;padding:0;"></a>&#160;<a title="Subscribe by RSS" href="https://feeds.hanselman.com/_/20/953212253/category"><img height="20" src="https://assets.feedblitz.com/i/rss20.png" style="border:0;margin:0;padding:0;"></a>&nbsp;<h3 style="clear:left;padding-top:10px">Related Stories</h3><ul><li><a rel="NOFOLLOW" href="https://ncbn.bio/north-carolina-biotech-news/2026/04/02/triangle-startups-raised-64m-in-march-as-venture-funds-closed-on-millions-more/?utm_source=rss&utm_medium=rss&utm_campaign=five-early-stage-startups-join-new-charlotte-program-at-the-pearl&utm_source=rss&utm_medium=rss&utm_campaign=triangle-startups-raised-64m-in-march-as-venture-funds-closed-on-millions-more">Triangle startups raised $64M in March as venture funds closed on millions more</a></li><li><a rel="NOFOLLOW" href="https://ncbn.bio/north-carolina-biotech-news/2026/04/01/unc-health-brings-back-veteran-leader-to-guide-coastal-expansion/?utm_source=rss&utm_medium=rss&utm_campaign=unc-health-brings-back-veteran-leader-to-guide-coastal-expansion&utm_source=rss&utm_medium=rss&utm_campaign=unc-health-brings-back-veteran-leader-to-guide-coastal-expansion">UNC Health brings back veteran leader to guide coastal expansion</a></li><li><a rel="NOFOLLOW" href="https://ncbn.bio/north-carolina-biotech-news/2026/04/01/peptonics-solves-cell-culture-defoaming-debacle/?utm_source=rss&utm_medium=rss&utm_campaign=unc-health-brings-back-veteran-leader-to-guide-coastal-expansion&utm_source=rss&utm_medium=rss&utm_campaign=peptonics-solves-cell-culture-defoaming-debacle">Peptonics Solves Cell Culture Defoaming Debacle</a></li></ul>&#160;</div>]]>
</description><content:encoded><![CDATA[<p><img width="200" height="133" src="https://biotechnetworks.org/wp-content/uploads/2026/04/why-a-former-lego-lead-left-the-toy-giant-to-reinvent-social-gaming.jpg" class="attachment-post-thumbnail size-post-thumbnail wp-post-image" alt="" decoding="async" /></p>A former LEGO designer is targeting workplace loneliness with a handcrafted tabletop game manufactured in Chapel Hill. Click here to view original post Click Here to Publish/Feature Your Company or Product News with Biotech Networks <a class="mh-excerpt-more" href="https://feeds.hanselman.com/~/t/0/0/category/~https://ncbn.bio/north-carolina-biotech-news/2026/04/03/why-a-former-lego-lead-left-the-toy-giant-to-reinvent-social-gaming/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=injectable-microgel-developed-to-reduce-bleeding-in-infants-undergoing-surgery" title="Why a former Lego lead left the toy giant to reinvent social gaming">[...]</a><Img align="left" border="0" height="1" width="1" alt="" style="border:0;float:left;margin:0;padding:0;width:1px!important;height:1px!important;" hspace="0" src="https://feeds.hanselman.com/~/i/953212253/0/category">
<div style="clear:both;padding-top:0.2em;"><a title="Like on Facebook" href="https://feeds.hanselman.com/_/28/953212253/category"><img height="20" src="https://assets.feedblitz.com/i/fblike20.png" style="border:0;margin:0;padding:0;"></a>&#160;<a title="Pin it!" href="https://feeds.hanselman.com/_/29/953212253/category,https%3a%2f%2fbiotechnetworks.org%2fwp-content%2fuploads%2f2026%2f04%2fwhy-a-former-lego-lead-left-the-toy-giant-to-reinvent-social-gaming.jpg"><img height="20" src="https://assets.feedblitz.com/i/pinterest20.png" style="border:0;margin:0;padding:0;"></a>&#160;<a title="Post to X.com" href="https://feeds.hanselman.com/_/24/953212253/category"><img height="20" src="https://assets.feedblitz.com/i/x.png" style="border:0;margin:0;padding:0;"></a>&#160;<a title="Subscribe by email" href="https://feeds.hanselman.com/_/19/953212253/category"><img height="20" src="https://assets.feedblitz.com/i/email20.png" style="border:0;margin:0;padding:0;"></a>&#160;<a title="Subscribe by RSS" href="https://feeds.hanselman.com/_/20/953212253/category"><img height="20" src="https://assets.feedblitz.com/i/rss20.png" style="border:0;margin:0;padding:0;"></a>&nbsp;<h3 style="clear:left;padding-top:10px">Related Stories</h3><ul><li><a rel="NOFOLLOW" href="https://ncbn.bio/north-carolina-biotech-news/2026/04/02/triangle-startups-raised-64m-in-march-as-venture-funds-closed-on-millions-more/?utm_source=rss&utm_medium=rss&utm_campaign=five-early-stage-startups-join-new-charlotte-program-at-the-pearl&utm_source=rss&utm_medium=rss&utm_campaign=triangle-startups-raised-64m-in-march-as-venture-funds-closed-on-millions-more">Triangle startups raised $64M in March as venture funds closed on millions more</a></li><li><a rel="NOFOLLOW" href="https://ncbn.bio/north-carolina-biotech-news/2026/04/01/unc-health-brings-back-veteran-leader-to-guide-coastal-expansion/?utm_source=rss&utm_medium=rss&utm_campaign=unc-health-brings-back-veteran-leader-to-guide-coastal-expansion&utm_source=rss&utm_medium=rss&utm_campaign=unc-health-brings-back-veteran-leader-to-guide-coastal-expansion">UNC Health brings back veteran leader to guide coastal expansion</a></li><li><a rel="NOFOLLOW" href="https://ncbn.bio/north-carolina-biotech-news/2026/04/01/peptonics-solves-cell-culture-defoaming-debacle/?utm_source=rss&utm_medium=rss&utm_campaign=unc-health-brings-back-veteran-leader-to-guide-coastal-expansion&utm_source=rss&utm_medium=rss&utm_campaign=peptonics-solves-cell-culture-defoaming-debacle">Peptonics Solves Cell Culture Defoaming Debacle</a></li></ul>&#160;</div>]]>
</content:encoded></item>
<item>
<feedburner:origLink>https://sdbn.org/san-diego-biotech-news/2026/03/11/ixcells-biotechnologies-reaches-ipsc-line-delivery-milestone-in-collaboration-with-global-biotechnology-company/?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=ixcells-biotechnologies-reaches-ipsc-line-delivery-milestone-in-collaboration-with-global-biotechnology-company</feedburner:origLink>
		<title>iXCells Biotechnologies Reaches iPSC Line Delivery Milestone in Collaboration With Global Biotechnology Company</title>
		<link>https://feeds.hanselman.com/~/953154419/0/category~iXCells-Biotechnologies-Reaches-iPSC-Line-Delivery-Milestone-in-Collaboration-With-Global-Biotechnology-Company/</link>
		
		<dc:creator><![CDATA[SDBN]]></dc:creator>
		<pubDate>Fri, 03 Apr 2026 08:07:43 +0000</pubDate>
				<category><![CDATA[News]]></category>
		<category><![CDATA[San Diego Biotech Trending News]]></category>
		<category><![CDATA[Syndication]]></category>
		<guid isPermaLink="false">http://www.inoreader.com/article/3a9c6e76e00b5b47</guid>
					<description><![CDATA[SAN DIEGO–(BUSINESS WIRE)–iXCells Biotechnologies USA, Inc. (“iXCells”), a leading provider of human cell-based solutions and custom iPSC services, today announced the delivery of over 500 characterized induced pluripotent stem cell (iPSC) lines as part of <a rel="NOFOLLOW" class="mh-excerpt-more" href="https://sdbn.org/san-diego-biotech-news/2026/03/11/ixcells-biotechnologies-reaches-ipsc-line-delivery-milestone-in-collaboration-with-global-biotechnology-company/" title="iXCells Biotechnologies Reaches iPSC Line Delivery Milestone in Collaboration With Global Biotechnology Company">[...]</a><div style="clear:both;padding-top:0.2em;"><a title="Like on Facebook" href="https://feeds.hanselman.com/_/28/953154419/category"><img height="20" src="https://assets.feedblitz.com/i/fblike20.png" style="border:0;margin:0;padding:0;"></a>&#160;<a title="Pin it!" href="https://feeds.hanselman.com/_/29/953154419/category,"><img height="20" src="https://assets.feedblitz.com/i/pinterest20.png" style="border:0;margin:0;padding:0;"></a>&#160;<a title="Post to X.com" href="https://feeds.hanselman.com/_/24/953154419/category"><img height="20" src="https://assets.feedblitz.com/i/x.png" style="border:0;margin:0;padding:0;"></a>&#160;<a title="Subscribe by email" href="https://feeds.hanselman.com/_/19/953154419/category"><img height="20" src="https://assets.feedblitz.com/i/email20.png" style="border:0;margin:0;padding:0;"></a>&#160;<a title="Subscribe by RSS" href="https://feeds.hanselman.com/_/20/953154419/category"><img height="20" src="https://assets.feedblitz.com/i/rss20.png" style="border:0;margin:0;padding:0;"></a>&nbsp;<h3 style="clear:left;padding-top:10px">Related Stories</h3><ul><li><a rel="NOFOLLOW" href="https://sdbn.org/san-diego-biotech-news/2026/04/03/grandevity-launches-vitality-and-energy-for-adults-aged-50-to-100/?utm_source=rss&utm_medium=rss&utm_campaign=grandevity-launches-vitality-and-energy-for-adults-aged-50-to-100">GRANDEVITY Launches: Vitality and Energy for Adults Aged 50 to 100</a></li><li><a rel="NOFOLLOW" href="https://sdbn.org/san-diego-biotech-news/2026/04/02/unprecedented-early-stage-cancer-detection-presented-at-aacr-2026/?utm_source=rss&utm_medium=rss&utm_campaign=unprecedented-early-stage-cancer-detection-presented-at-aacr-2026">Unprecedented Early-Stage Cancer Detection Presented at AACR 2026</a></li><li><a rel="NOFOLLOW" href="https://sdbn.org/wp-content/uploads/2026/04/uc-san-diego-school-of-medicine-ranked-no-4-nationally-for-nih-funding-among-public-institutions-1024x536.png">UC San Diego School of Medicine Ranked No. 4 Nationally for NIH Funding Among Public Institutions - Enclosure</a></li></ul>&#160;</div>]]>
</description><content:encoded><![CDATA[SAN DIEGO–(BUSINESS WIRE)–iXCells Biotechnologies USA, Inc. (“iXCells”), a leading provider of human cell-based solutions and custom iPSC services, today announced the delivery of over 500 characterized induced pluripotent stem cell (iPSC) lines as part of <a class="mh-excerpt-more" href="https://feeds.hanselman.com/~/t/0/0/category/~https://sdbn.org/san-diego-biotech-news/2026/03/11/ixcells-biotechnologies-reaches-ipsc-line-delivery-milestone-in-collaboration-with-global-biotechnology-company/" title="iXCells Biotechnologies Reaches iPSC Line Delivery Milestone in Collaboration With Global Biotechnology Company">[...]</a><Img align="left" border="0" height="1" width="1" alt="" style="border:0;float:left;margin:0;padding:0;width:1px!important;height:1px!important;" hspace="0" src="https://feeds.hanselman.com/~/i/953154419/0/category">
<div style="clear:both;padding-top:0.2em;"><a title="Like on Facebook" href="https://feeds.hanselman.com/_/28/953154419/category"><img height="20" src="https://assets.feedblitz.com/i/fblike20.png" style="border:0;margin:0;padding:0;"></a>&#160;<a title="Pin it!" href="https://feeds.hanselman.com/_/29/953154419/category,"><img height="20" src="https://assets.feedblitz.com/i/pinterest20.png" style="border:0;margin:0;padding:0;"></a>&#160;<a title="Post to X.com" href="https://feeds.hanselman.com/_/24/953154419/category"><img height="20" src="https://assets.feedblitz.com/i/x.png" style="border:0;margin:0;padding:0;"></a>&#160;<a title="Subscribe by email" href="https://feeds.hanselman.com/_/19/953154419/category"><img height="20" src="https://assets.feedblitz.com/i/email20.png" style="border:0;margin:0;padding:0;"></a>&#160;<a title="Subscribe by RSS" href="https://feeds.hanselman.com/_/20/953154419/category"><img height="20" src="https://assets.feedblitz.com/i/rss20.png" style="border:0;margin:0;padding:0;"></a>&nbsp;<h3 style="clear:left;padding-top:10px">Related Stories</h3><ul><li><a rel="NOFOLLOW" href="https://sdbn.org/san-diego-biotech-news/2026/04/03/grandevity-launches-vitality-and-energy-for-adults-aged-50-to-100/?utm_source=rss&utm_medium=rss&utm_campaign=grandevity-launches-vitality-and-energy-for-adults-aged-50-to-100">GRANDEVITY Launches: Vitality and Energy for Adults Aged 50 to 100</a></li><li><a rel="NOFOLLOW" href="https://sdbn.org/san-diego-biotech-news/2026/04/02/unprecedented-early-stage-cancer-detection-presented-at-aacr-2026/?utm_source=rss&utm_medium=rss&utm_campaign=unprecedented-early-stage-cancer-detection-presented-at-aacr-2026">Unprecedented Early-Stage Cancer Detection Presented at AACR 2026</a></li><li><a rel="NOFOLLOW" href="https://sdbn.org/wp-content/uploads/2026/04/uc-san-diego-school-of-medicine-ranked-no-4-nationally-for-nih-funding-among-public-institutions-1024x536.png">UC San Diego School of Medicine Ranked No. 4 Nationally for NIH Funding Among Public Institutions - Enclosure</a></li></ul>&#160;</div>]]>
</content:encoded></item>
<item>
<feedburner:origLink>https://sdbn.org/san-diego-biotech-news/2026/04/02/unprecedented-early-stage-cancer-detection-presented-at-aacr-2026/?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=unprecedented-early-stage-cancer-detection-presented-at-aacr-2026</feedburner:origLink>
		<title>Unprecedented Early-Stage Cancer Detection Presented at AACR 2026</title>
		<link>https://feeds.hanselman.com/~/953154422/0/category~Unprecedented-EarlyStage-Cancer-Detection-Presented-at-AACR/</link>
		
		<dc:creator><![CDATA[SDBN]]></dc:creator>
		<pubDate>Fri, 03 Apr 2026 07:04:01 +0000</pubDate>
				<category><![CDATA[News]]></category>
		<category><![CDATA[San Diego Biotech Trending News]]></category>
		<category><![CDATA[Syndication]]></category>
		<guid isPermaLink="false">http://www.inoreader.com/article/3a9c6e76e1f3aa93</guid>
					<description><![CDATA[GLASGOW, Scotland–(BUSINESS WIRE)–Dxcover, a global leader in AI-enabled technologies, today announced the presentation of multiple studies at the American Association for Cancer Research (AACR) Annual Meeting taking place in San Diego, California this month. The <a rel="NOFOLLOW" class="mh-excerpt-more" href="https://sdbn.org/san-diego-biotech-news/2026/04/02/unprecedented-early-stage-cancer-detection-presented-at-aacr-2026/" title="Unprecedented Early-Stage Cancer Detection Presented at AACR 2026">[...]</a><div style="clear:both;padding-top:0.2em;"><a title="Like on Facebook" href="https://feeds.hanselman.com/_/28/953154422/category"><img height="20" src="https://assets.feedblitz.com/i/fblike20.png" style="border:0;margin:0;padding:0;"></a>&#160;<a title="Pin it!" href="https://feeds.hanselman.com/_/29/953154422/category,"><img height="20" src="https://assets.feedblitz.com/i/pinterest20.png" style="border:0;margin:0;padding:0;"></a>&#160;<a title="Post to X.com" href="https://feeds.hanselman.com/_/24/953154422/category"><img height="20" src="https://assets.feedblitz.com/i/x.png" style="border:0;margin:0;padding:0;"></a>&#160;<a title="Subscribe by email" href="https://feeds.hanselman.com/_/19/953154422/category"><img height="20" src="https://assets.feedblitz.com/i/email20.png" style="border:0;margin:0;padding:0;"></a>&#160;<a title="Subscribe by RSS" href="https://feeds.hanselman.com/_/20/953154422/category"><img height="20" src="https://assets.feedblitz.com/i/rss20.png" style="border:0;margin:0;padding:0;"></a>&nbsp;<h3 style="clear:left;padding-top:10px">Related Stories</h3><ul><li><a rel="NOFOLLOW" href="https://sdbn.org/san-diego-biotech-news/2026/04/03/grandevity-launches-vitality-and-energy-for-adults-aged-50-to-100/?utm_source=rss&utm_medium=rss&utm_campaign=grandevity-launches-vitality-and-energy-for-adults-aged-50-to-100">GRANDEVITY Launches: Vitality and Energy for Adults Aged 50 to 100</a></li><li><a rel="NOFOLLOW" href="https://sdbn.org/san-diego-biotech-news/2026/03/11/ixcells-biotechnologies-reaches-ipsc-line-delivery-milestone-in-collaboration-with-global-biotechnology-company/?utm_source=rss&utm_medium=rss&utm_campaign=ixcells-biotechnologies-reaches-ipsc-line-delivery-milestone-in-collaboration-with-global-biotechnology-company">iXCells Biotechnologies Reaches iPSC Line Delivery Milestone in Collaboration With Global Biotechnology Company</a></li><li><a rel="NOFOLLOW" href="https://sdbn.org/wp-content/uploads/2026/04/uc-san-diego-school-of-medicine-ranked-no-4-nationally-for-nih-funding-among-public-institutions-1024x536.png">UC San Diego School of Medicine Ranked No. 4 Nationally for NIH Funding Among Public Institutions - Enclosure</a></li></ul>&#160;</div>]]>
</description><content:encoded><![CDATA[GLASGOW, Scotland–(BUSINESS WIRE)–Dxcover, a global leader in AI-enabled technologies, today announced the presentation of multiple studies at the American Association for Cancer Research (AACR) Annual Meeting taking place in San Diego, California this month. The <a class="mh-excerpt-more" href="https://feeds.hanselman.com/~/t/0/0/category/~https://sdbn.org/san-diego-biotech-news/2026/04/02/unprecedented-early-stage-cancer-detection-presented-at-aacr-2026/" title="Unprecedented Early-Stage Cancer Detection Presented at AACR 2026">[...]</a><Img align="left" border="0" height="1" width="1" alt="" style="border:0;float:left;margin:0;padding:0;width:1px!important;height:1px!important;" hspace="0" src="https://feeds.hanselman.com/~/i/953154422/0/category">
<div style="clear:both;padding-top:0.2em;"><a title="Like on Facebook" href="https://feeds.hanselman.com/_/28/953154422/category"><img height="20" src="https://assets.feedblitz.com/i/fblike20.png" style="border:0;margin:0;padding:0;"></a>&#160;<a title="Pin it!" href="https://feeds.hanselman.com/_/29/953154422/category,"><img height="20" src="https://assets.feedblitz.com/i/pinterest20.png" style="border:0;margin:0;padding:0;"></a>&#160;<a title="Post to X.com" href="https://feeds.hanselman.com/_/24/953154422/category"><img height="20" src="https://assets.feedblitz.com/i/x.png" style="border:0;margin:0;padding:0;"></a>&#160;<a title="Subscribe by email" href="https://feeds.hanselman.com/_/19/953154422/category"><img height="20" src="https://assets.feedblitz.com/i/email20.png" style="border:0;margin:0;padding:0;"></a>&#160;<a title="Subscribe by RSS" href="https://feeds.hanselman.com/_/20/953154422/category"><img height="20" src="https://assets.feedblitz.com/i/rss20.png" style="border:0;margin:0;padding:0;"></a>&nbsp;<h3 style="clear:left;padding-top:10px">Related Stories</h3><ul><li><a rel="NOFOLLOW" href="https://sdbn.org/san-diego-biotech-news/2026/04/03/grandevity-launches-vitality-and-energy-for-adults-aged-50-to-100/?utm_source=rss&utm_medium=rss&utm_campaign=grandevity-launches-vitality-and-energy-for-adults-aged-50-to-100">GRANDEVITY Launches: Vitality and Energy for Adults Aged 50 to 100</a></li><li><a rel="NOFOLLOW" href="https://sdbn.org/san-diego-biotech-news/2026/03/11/ixcells-biotechnologies-reaches-ipsc-line-delivery-milestone-in-collaboration-with-global-biotechnology-company/?utm_source=rss&utm_medium=rss&utm_campaign=ixcells-biotechnologies-reaches-ipsc-line-delivery-milestone-in-collaboration-with-global-biotechnology-company">iXCells Biotechnologies Reaches iPSC Line Delivery Milestone in Collaboration With Global Biotechnology Company</a></li><li><a rel="NOFOLLOW" href="https://sdbn.org/wp-content/uploads/2026/04/uc-san-diego-school-of-medicine-ranked-no-4-nationally-for-nih-funding-among-public-institutions-1024x536.png">UC San Diego School of Medicine Ranked No. 4 Nationally for NIH Funding Among Public Institutions - Enclosure</a></li></ul>&#160;</div>]]>
</content:encoded></item>
<item>
<feedburner:origLink>https://bcbn.org/boston-cambridge-biotech-news/2026/04/01/flagship-pioneering-and-aws-announce-collaboration-to-accelerate-drug-discovery-and-life-sciences-innovation/?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=toward-cheaper-cleaner-hydrogen-production&amp;utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=flagship-pioneering-and-aws-announce-collaboration-to-accelerate-drug-discovery-and-life-sciences-innovation</feedburner:origLink>
		<title>Flagship Pioneering and AWS Announce Collaboration to Accelerate Drug Discovery and Life Sciences Innovation</title>
		<link>https://feeds.hanselman.com/~/953150297/0/category~Flagship-Pioneering-and-AWS-Announce-Collaboration-to-Accelerate-Drug-Discovery-and-Life-Sciences-Innovation/</link>
		
		<dc:creator><![CDATA[BCBN]]></dc:creator>
		<pubDate>Fri, 03 Apr 2026 06:00:49 +0000</pubDate>
				<category><![CDATA[Boston Cambridge Biotech Trending News]]></category>
		<category><![CDATA[Syndication]]></category>
		<guid isPermaLink="false">http://www.inoreader.com/article/3a9c6e76e1fb5a19</guid>
					<description><![CDATA[Flagship’s early-stage companies to receive AWS cloud credits, technical support, and AI capabilities to accelerate drug discovery and scientific platforms CAMBRIDGE, Mass., April 1, 2026 /PRNewswire/ — Flagship Pioneering, a scientific innovation engine for transformative <a rel="NOFOLLOW" class="mh-excerpt-more" href="https://bcbn.org/boston-cambridge-biotech-news/2026/04/01/flagship-pioneering-and-aws-announce-collaboration-to-accelerate-drug-discovery-and-life-sciences-innovation/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=toward-cheaper-cleaner-hydrogen-production" title="Flagship Pioneering and AWS Announce Collaboration to Accelerate Drug Discovery and Life Sciences Innovation">[...]</a><div style="clear:both;padding-top:0.2em;"><a title="Like on Facebook" href="https://feeds.hanselman.com/_/28/953150297/category"><img height="20" src="https://assets.feedblitz.com/i/fblike20.png" style="border:0;margin:0;padding:0;"></a>&#160;<a title="Pin it!" href="https://feeds.hanselman.com/_/29/953150297/category,"><img height="20" src="https://assets.feedblitz.com/i/pinterest20.png" style="border:0;margin:0;padding:0;"></a>&#160;<a title="Post to X.com" href="https://feeds.hanselman.com/_/24/953150297/category"><img height="20" src="https://assets.feedblitz.com/i/x.png" style="border:0;margin:0;padding:0;"></a>&#160;<a title="Subscribe by email" href="https://feeds.hanselman.com/_/19/953150297/category"><img height="20" src="https://assets.feedblitz.com/i/email20.png" style="border:0;margin:0;padding:0;"></a>&#160;<a title="Subscribe by RSS" href="https://feeds.hanselman.com/_/20/953150297/category"><img height="20" src="https://assets.feedblitz.com/i/rss20.png" style="border:0;margin:0;padding:0;"></a>&nbsp;<h3 style="clear:left;padding-top:10px">Related Stories</h3><ul><li><a rel="NOFOLLOW" href="https://bcbn.org/boston-cambridge-biotech-news/2026/04/02/vericel-announces-barda-award-valued-at-up-to-197-million-for-procurement-and-advanced-development-of-nexobrid/?utm_source=rss&utm_medium=rss&utm_campaign=the-value-of-hope-drug-pricing-more-at-massbios-state-of-possible&utm_source=rss&utm_medium=rss&utm_campaign=vericel-announces-barda-award-valued-at-up-to-197-million-for-procurement-and-advanced-development-of-nexobrid">Vericel Announces BARDA Award Valued at up to $197 Million for Procurement and Advanced Development of NexoBrid</a></li><li><a rel="NOFOLLOW" href="https://bcbn.org/boston-cambridge-biotech-news/2026/04/02/sv-health-investors-acquires-epivax/?utm_source=rss&utm_medium=rss&utm_campaign=the-value-of-hope-drug-pricing-more-at-massbios-state-of-possible&utm_source=rss&utm_medium=rss&utm_campaign=sv-health-investors-acquires-epivax">SV Health Investors Acquires EpiVax</a></li><li><a rel="NOFOLLOW" href="https://bcbn.org/boston-cambridge-biotech-news/2026/04/03/the-value-of-hope-drug-pricing-more-at-massbios-state-of-possible/?utm_source=rss&utm_medium=rss&utm_campaign=the-value-of-hope-drug-pricing-more-at-massbios-state-of-possible">The Value of Hope: Drug Pricing &#038; More at MassBio’s State of Possible</a></li></ul>&#160;</div>]]>
</description><content:encoded><![CDATA[Flagship’s early-stage companies to receive AWS cloud credits, technical support, and AI capabilities to accelerate drug discovery and scientific platforms CAMBRIDGE, Mass., April 1, 2026 /PRNewswire/ — Flagship Pioneering, a scientific innovation engine for transformative <a class="mh-excerpt-more" href="https://feeds.hanselman.com/~/t/0/0/category/~https://bcbn.org/boston-cambridge-biotech-news/2026/04/01/flagship-pioneering-and-aws-announce-collaboration-to-accelerate-drug-discovery-and-life-sciences-innovation/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=toward-cheaper-cleaner-hydrogen-production" title="Flagship Pioneering and AWS Announce Collaboration to Accelerate Drug Discovery and Life Sciences Innovation">[...]</a><Img align="left" border="0" height="1" width="1" alt="" style="border:0;float:left;margin:0;padding:0;width:1px!important;height:1px!important;" hspace="0" src="https://feeds.hanselman.com/~/i/953150297/0/category">
<div style="clear:both;padding-top:0.2em;"><a title="Like on Facebook" href="https://feeds.hanselman.com/_/28/953150297/category"><img height="20" src="https://assets.feedblitz.com/i/fblike20.png" style="border:0;margin:0;padding:0;"></a>&#160;<a title="Pin it!" href="https://feeds.hanselman.com/_/29/953150297/category,"><img height="20" src="https://assets.feedblitz.com/i/pinterest20.png" style="border:0;margin:0;padding:0;"></a>&#160;<a title="Post to X.com" href="https://feeds.hanselman.com/_/24/953150297/category"><img height="20" src="https://assets.feedblitz.com/i/x.png" style="border:0;margin:0;padding:0;"></a>&#160;<a title="Subscribe by email" href="https://feeds.hanselman.com/_/19/953150297/category"><img height="20" src="https://assets.feedblitz.com/i/email20.png" style="border:0;margin:0;padding:0;"></a>&#160;<a title="Subscribe by RSS" href="https://feeds.hanselman.com/_/20/953150297/category"><img height="20" src="https://assets.feedblitz.com/i/rss20.png" style="border:0;margin:0;padding:0;"></a>&nbsp;<h3 style="clear:left;padding-top:10px">Related Stories</h3><ul><li><a rel="NOFOLLOW" href="https://bcbn.org/boston-cambridge-biotech-news/2026/04/02/vericel-announces-barda-award-valued-at-up-to-197-million-for-procurement-and-advanced-development-of-nexobrid/?utm_source=rss&utm_medium=rss&utm_campaign=the-value-of-hope-drug-pricing-more-at-massbios-state-of-possible&utm_source=rss&utm_medium=rss&utm_campaign=vericel-announces-barda-award-valued-at-up-to-197-million-for-procurement-and-advanced-development-of-nexobrid">Vericel Announces BARDA Award Valued at up to $197 Million for Procurement and Advanced Development of NexoBrid</a></li><li><a rel="NOFOLLOW" href="https://bcbn.org/boston-cambridge-biotech-news/2026/04/02/sv-health-investors-acquires-epivax/?utm_source=rss&utm_medium=rss&utm_campaign=the-value-of-hope-drug-pricing-more-at-massbios-state-of-possible&utm_source=rss&utm_medium=rss&utm_campaign=sv-health-investors-acquires-epivax">SV Health Investors Acquires EpiVax</a></li><li><a rel="NOFOLLOW" href="https://bcbn.org/boston-cambridge-biotech-news/2026/04/03/the-value-of-hope-drug-pricing-more-at-massbios-state-of-possible/?utm_source=rss&utm_medium=rss&utm_campaign=the-value-of-hope-drug-pricing-more-at-massbios-state-of-possible">The Value of Hope: Drug Pricing &#038; More at MassBio’s State of Possible</a></li></ul>&#160;</div>]]>
</content:encoded></item>
<item>
<feedburner:origLink>https://bcbn.org/boston-cambridge-biotech-news/2026/03/31/merck-quotient-launch-up-to-2-2b-somatic-genomics-collaboration-in-ibd/?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=toward-cheaper-cleaner-hydrogen-production&amp;utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=merck-quotient-launch-up-to-2-2b-somatic-genomics-collaboration-in-ibd</feedburner:origLink>
		<title>Merck, Quotient Launch Up-to-$2.2B Somatic Genomics Collaboration in IBD</title>
		<link>https://feeds.hanselman.com/~/953150300/0/category~Merck-Quotient-Launch-UptoB-Somatic-Genomics-Collaboration-in-IBD/</link>
		
		<dc:creator><![CDATA[BCBN]]></dc:creator>
		<pubDate>Fri, 03 Apr 2026 06:00:49 +0000</pubDate>
				<category><![CDATA[Boston Cambridge Biotech Trending News]]></category>
		<category><![CDATA[Syndication]]></category>
		<guid isPermaLink="false">http://www.inoreader.com/article/3a9c6e76e1fb5a17</guid>
					<description><![CDATA[Merck &#38; Co. will apply the somatic genomics platform of Quotient Therapeutics to discover novel drug targets in inflammatory bowel disease (IBD), through a collaboration that could generate up to $2.2 billion for the four-year-old <a rel="NOFOLLOW" class="mh-excerpt-more" href="https://bcbn.org/boston-cambridge-biotech-news/2026/03/31/merck-quotient-launch-up-to-2-2b-somatic-genomics-collaboration-in-ibd/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=toward-cheaper-cleaner-hydrogen-production" title="Merck, Quotient Launch Up-to-$2.2B Somatic Genomics Collaboration in IBD">[...]</a><div style="clear:both;padding-top:0.2em;"><a title="Like on Facebook" href="https://feeds.hanselman.com/_/28/953150300/category"><img height="20" src="https://assets.feedblitz.com/i/fblike20.png" style="border:0;margin:0;padding:0;"></a>&#160;<a title="Pin it!" href="https://feeds.hanselman.com/_/29/953150300/category,"><img height="20" src="https://assets.feedblitz.com/i/pinterest20.png" style="border:0;margin:0;padding:0;"></a>&#160;<a title="Post to X.com" href="https://feeds.hanselman.com/_/24/953150300/category"><img height="20" src="https://assets.feedblitz.com/i/x.png" style="border:0;margin:0;padding:0;"></a>&#160;<a title="Subscribe by email" href="https://feeds.hanselman.com/_/19/953150300/category"><img height="20" src="https://assets.feedblitz.com/i/email20.png" style="border:0;margin:0;padding:0;"></a>&#160;<a title="Subscribe by RSS" href="https://feeds.hanselman.com/_/20/953150300/category"><img height="20" src="https://assets.feedblitz.com/i/rss20.png" style="border:0;margin:0;padding:0;"></a>&nbsp;<h3 style="clear:left;padding-top:10px">Related Stories</h3><ul><li><a rel="NOFOLLOW" href="https://bcbn.org/boston-cambridge-biotech-news/2026/04/02/vericel-announces-barda-award-valued-at-up-to-197-million-for-procurement-and-advanced-development-of-nexobrid/?utm_source=rss&utm_medium=rss&utm_campaign=the-value-of-hope-drug-pricing-more-at-massbios-state-of-possible&utm_source=rss&utm_medium=rss&utm_campaign=vericel-announces-barda-award-valued-at-up-to-197-million-for-procurement-and-advanced-development-of-nexobrid">Vericel Announces BARDA Award Valued at up to $197 Million for Procurement and Advanced Development of NexoBrid</a></li><li><a rel="NOFOLLOW" href="https://bcbn.org/boston-cambridge-biotech-news/2026/04/02/sv-health-investors-acquires-epivax/?utm_source=rss&utm_medium=rss&utm_campaign=the-value-of-hope-drug-pricing-more-at-massbios-state-of-possible&utm_source=rss&utm_medium=rss&utm_campaign=sv-health-investors-acquires-epivax">SV Health Investors Acquires EpiVax</a></li><li><a rel="NOFOLLOW" href="https://bcbn.org/boston-cambridge-biotech-news/2026/04/03/the-value-of-hope-drug-pricing-more-at-massbios-state-of-possible/?utm_source=rss&utm_medium=rss&utm_campaign=the-value-of-hope-drug-pricing-more-at-massbios-state-of-possible">The Value of Hope: Drug Pricing &#038; More at MassBio’s State of Possible</a></li></ul>&#160;</div>]]>
</description><content:encoded><![CDATA[Merck &#38; Co. will apply the somatic genomics platform of Quotient Therapeutics to discover novel drug targets in inflammatory bowel disease (IBD), through a collaboration that could generate up to $2.2 billion for the four-year-old <a class="mh-excerpt-more" href="https://feeds.hanselman.com/~/t/0/0/category/~https://bcbn.org/boston-cambridge-biotech-news/2026/03/31/merck-quotient-launch-up-to-2-2b-somatic-genomics-collaboration-in-ibd/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=toward-cheaper-cleaner-hydrogen-production" title="Merck, Quotient Launch Up-to-$2.2B Somatic Genomics Collaboration in IBD">[...]</a><Img align="left" border="0" height="1" width="1" alt="" style="border:0;float:left;margin:0;padding:0;width:1px!important;height:1px!important;" hspace="0" src="https://feeds.hanselman.com/~/i/953150300/0/category">
<div style="clear:both;padding-top:0.2em;"><a title="Like on Facebook" href="https://feeds.hanselman.com/_/28/953150300/category"><img height="20" src="https://assets.feedblitz.com/i/fblike20.png" style="border:0;margin:0;padding:0;"></a>&#160;<a title="Pin it!" href="https://feeds.hanselman.com/_/29/953150300/category,"><img height="20" src="https://assets.feedblitz.com/i/pinterest20.png" style="border:0;margin:0;padding:0;"></a>&#160;<a title="Post to X.com" href="https://feeds.hanselman.com/_/24/953150300/category"><img height="20" src="https://assets.feedblitz.com/i/x.png" style="border:0;margin:0;padding:0;"></a>&#160;<a title="Subscribe by email" href="https://feeds.hanselman.com/_/19/953150300/category"><img height="20" src="https://assets.feedblitz.com/i/email20.png" style="border:0;margin:0;padding:0;"></a>&#160;<a title="Subscribe by RSS" href="https://feeds.hanselman.com/_/20/953150300/category"><img height="20" src="https://assets.feedblitz.com/i/rss20.png" style="border:0;margin:0;padding:0;"></a>&nbsp;<h3 style="clear:left;padding-top:10px">Related Stories</h3><ul><li><a rel="NOFOLLOW" href="https://bcbn.org/boston-cambridge-biotech-news/2026/04/02/vericel-announces-barda-award-valued-at-up-to-197-million-for-procurement-and-advanced-development-of-nexobrid/?utm_source=rss&utm_medium=rss&utm_campaign=the-value-of-hope-drug-pricing-more-at-massbios-state-of-possible&utm_source=rss&utm_medium=rss&utm_campaign=vericel-announces-barda-award-valued-at-up-to-197-million-for-procurement-and-advanced-development-of-nexobrid">Vericel Announces BARDA Award Valued at up to $197 Million for Procurement and Advanced Development of NexoBrid</a></li><li><a rel="NOFOLLOW" href="https://bcbn.org/boston-cambridge-biotech-news/2026/04/02/sv-health-investors-acquires-epivax/?utm_source=rss&utm_medium=rss&utm_campaign=the-value-of-hope-drug-pricing-more-at-massbios-state-of-possible&utm_source=rss&utm_medium=rss&utm_campaign=sv-health-investors-acquires-epivax">SV Health Investors Acquires EpiVax</a></li><li><a rel="NOFOLLOW" href="https://bcbn.org/boston-cambridge-biotech-news/2026/04/03/the-value-of-hope-drug-pricing-more-at-massbios-state-of-possible/?utm_source=rss&utm_medium=rss&utm_campaign=the-value-of-hope-drug-pricing-more-at-massbios-state-of-possible">The Value of Hope: Drug Pricing &#038; More at MassBio’s State of Possible</a></li></ul>&#160;</div>]]>
</content:encoded></item>
</channel></rss>

